StudyManager Evolve(TM) Gaining Momentum in Chinese Market
Published: Aug 19, 2011
Both deployments represent significant milestones for StudyManager, which began its expansion into China in early 2009. Demand for StudyManager Evolve, the company’s sponsor/CRO-focused product, has gained traction internationally following the success of numerous clinical trials and increased market share in the U.S.
Evolve Gains Momentum as CROs in China Seek Integrated Study Management Tools
“With the increasing demand for EDC in the Chinese market, Evolve attracts more and more interest from Chinese CROs, especially with its ability to support Chinese language,” said Feng Cheng, Director, Asia Pacific Business Development at StudyManager. “We are happy that Evolve plays a very important role in GCP ClinPlus’ studies, of which there have been five using Evolve deployed over the past 18 months. It has been exciting to work with the GCP ClinPlus team – this is a milestone achievement for both companies.”
“We spent more than a year evaluating EDC systems that include both U.S. and Chinese vendors’ products,” said Dr. Ivan Zhai, CEO of GCP ClinPlus Ltd. “We selected Evolve as our EDC system because it is a simple, easy-to-use system that our sites are excited to use, with minimal user training. This should improve data entry compliance and data quality right from the start, while maintaining happy site users.”
Flexible, Cost-Effective, Easy to Use
Chongqing Jiachen Biotechnology Ltd. found Evolve to be flexible and easy to use – an ideal solution for managing data on behalf of the small- to mid-size biotechnology and pharmaceutical companies for which Chongqing Jiachen manages clinical trials.
“StudyManager Evolve is a product that meets our clinical trial needs,” said Joy Jin, Study Director, Chongqing Jiachen. “Most important, Evolve is U.S. FDA 21 CFR Part 11 compliant and therefore meets our global filing needs for a new hepatitis B treatment drug. StudyManager was willing to work with us to make this an affordable solution for a Chinese pharmaceutical company like Chongqing Jiachen. It's very clear that StudyManager understands the needs of its clients.”
Enhance Efficiency and Boost Productivity through Centralized Study Management
Evolve's web-based interface integrates clinical trial management and electronic data capture tools. These features are highly scalable, and can be used together seamlessly or independently. Evolve enables users to create a single, centralized and secure location for key study information, simplifying study operations and enhancing team efficiency.
About GCP ClinPlus Ltd.
GCP ClinPlus Ltd is a clinical research and services provider company with headquarters in Beijing, People’s Republic of China. The company was established in 2010 with the merger of Beijing DMS Pharma Ltd., YiXie ZhongTai MedTech Consulting Ltd, and Site Management Organization (SMO) business. As a new company, GCP ClinPlus is committed to provide services of biopharmaceutical product and medical device registration, pharmaceutical R&D, and clinical trial management.
About Chongqing Jiachen Biotechlogy Ltd.
Chongqing Jiachen Biotechnology Ltd. was established in 1998 by Chongqing Beer, The 3rd PLA Medication University, and Chongqing University. The company’s headquarters is located in Chongqing, China. Chongqing Jiachen has a 160,000 square footage GMP manufacturing facility and more than 30 drug products selling in China. The Phase II hepatitis B trials are one of the major studies in the company’s pipeline.
StudyManager (also known as Advanced Clinical Software) is a privately held company focused exclusively on developing solutions for the clinical trial industry. Evolve, StudyManager’s set of study management tools for Sponsors and CROs, has been successfully implemented by pharmaceutical, medical device, and biotech organizations, contract research organizations (CROs), and academic medical centers.
VP, Operations | StudyManager
206.957.7450 | firstname.lastname@example.org